MAPK1 and non-small cell lung carcinoma: Indeed, our GSEA and RNA-Seq data followed by functional assays confirmed that the oncogenic potential of GALNT2 in NSCLC was linked to the activation of the PI3K/Akt and MAPK/ERK pathways.